A targeting delivery platform for the mapping of responses to p53-independent intervention in heterogeneous patient cancer cells
Using a targeting delivery platform, this study developed an ex vivo blood-based model to evaluate therapeutic responses to p53-independent interventions in patient-derived cancer cells, thereby offering a promising approach for precision oncology.
Authors
- Si‐Xue Cheng (ORCID: https://orcid.org/0000-0001-9611-4421)
- Jin-Ju Lei (ORCID: https://orcid.org/0009-0004-2884-2573)
- Xin‐Ru Liao
- Chaojie Yang
- Di Han (ORCID: https://orcid.org/0009-0008-0395-1377)
- Li‐Jin Qi
- Qi-Yang Huang
- Qing-Yu Gao
- Fei-Fei Fu
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Journal of Materials Chemistry B
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6tb01990k
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wuhan University